Bioinformatics Market

Market Overview

The global bioinformatics market size was valued at USD 12,174 million in 2021, envisioned to reach USD 34,003 million in 2031, expanding at a CAGR of 13.7% during the forecast period.

The field of bioinformatics combines biology and information technology. It connects biological data with information collection, distribution, and evaluation tools to serve numerous aspects of scientific research, such as biomedicine. It utilizes several software tools for database construction, data management, warehousing, and mining. Data mining yields scientific discoveries applied to the study of genetics and genomes. Combining computer programming, big data, and biology, bioinformatics enables scientists to comprehend and detect patterns in biological data. It is precious in studying genomes and DNA sequencing since it allows scientists to arrange vast amounts of data. There are a variety of bioinformatics tools on the market. These are protein functional and analysis tools, homology and similarity tools, sequence analysis tools, and other tools.

The future growth of the worldwide bioinformatics industry is anticipated to be significant due to the rising need for integrated data and the expansion of proteomics and genomics. In addition, medication discovery and development are anticipated to fuel market expansion over the projection period. During the forecast period, however, a shortage of experienced individuals and standard data formats is expected to impede market expansion. In contrast, the rising demand for integrated solutions and systems is anticipated to create lucrative opportunities for market participants.

Market Dynamics

Market Driving Factors

The Growing Demand for Integrated Data and Development in Proteomics & Genomics

Investigations and clinical trial procedures, such as drug discovery procedures, create essential data. High throughput screening and target identification are two other vital applications that make a considerable volume of data and need efficient analysis. The field of bioinformatics is constantly at work towards building a wide variety of tools that can manage extensive and intricate data sets. These solutions streamline the process of delivering necessary data to end users. As a result, organizations in the pharmaceutical and biotechnology industries are drawn to these applications to handle their data. This propels growth in the bioinformatics market.

The number of studies being carried out in the field of OMICS (genomics, proteomics, and metabolomics) is continuously increasing, which helps boost the number of applications used in bioinformatics. It is anticipated that the OMICS technology would increase data analysis and storage demand. In proteomics and genomics, the platform and methodologies of bioinformatics play an essential part in collecting, analyzing, classifying, and characterizing information. This information contributes to the expansion of research in proteomics and genomes, which in turn aids in identifying treatments and preventative measures for various disorders. Thus, boosting bioinformatics market growth. 

Market Restraining Factors

The Scarcity of Skilled Personnel

The shortage of qualified individuals is one of the issues restraining the expansion of the bioinformatics market. Because an enormous amount of data needs to be processed, the tools utilized in bioinformatics are now only accessible to highly trained end users. This demand staffs that are both skilled and professional. In addition, the nature of the job performed by bioinformatics software is complex, which adds to the high expenses of operating the instruments. Because of this, personnel who perform the task must undergo training, which hinders the expansion of the bioinformatics market.

Market Opportunities

The Growth in the Need for Integrated Solutions & Systems

Product development and engineering must be innovative to remain competitive in the medical device sector. The area of bioinformatics is viewed as an information technology tool that deals with the recording, annotation, storage, analysis, and retrieval of nucleic acid sequence, protein sequence, and structural information. On the other hand, the bioinformatics industry is undergoing a progressive shift and is increasingly seen as an integrated instrument. The software utilized in bioinformatics is capable of integrating the data analysis and administration required for diverse applications, like genome sequencing. In addition, it has numerous applications in health and biology, including molecular medicines, preventive medicines, gene therapy, drug development, biotechnology, and forensic microbiology. Consequently, there is a growing demand for integrated solutions and systems in the healthcare sector. This further creates growth opportunities for the bioinformatics market share.

Regional Analysis

The region-wise segmentation of the global bioinformatics market includes North America, Europe, Asia-Pacific, and LAMEA.

North America and Europe Will Dominate the Regional Market

North America will command the market with the largest share while growing at a CAGR of 12.4%. The region's growth is attributable to increased demand for novel medication research and development and commercial and public funding initiatives to support research and development, which are anticipated to drive bioinformatics market expansion. In addition, the adoption of modern technology and the growing use of bioinformatics tools in Canada and Mexico is expected to stimulate the regional market. Moreover, the federal government regulates bioinformatics in the United States, which involves using health and genetic information to identify persons. Regulations shape the sector by limiting the disclosure of sensitive information and removing obstacles to collecting and processing electronic health and genetic records. This reduction of technological barriers makes bioinformatics user-friendly, hence fostering regional development.

Europe will hold a share of USD 12,666 million, growing at a CAGR of 14.2%. The region's expansion is attributable to the demand for bioinformatics tools for accurate and rapid analysis of biomarkers discovery programs, which aid in toxicity detection during the drug development process. In addition, governments concentrate on numerous programs to promote the advantages of bioinformatics by increasing funding in research and development, which has a favorable impact on the bioinformatics business in European Union nations. Certain obstacles impede the expansion of the bioinformatics market in Europe. Many European companies are hesitant to employ bioinformatics solutions because they believe these tools are limited to a small subset of end users. The market for bioinformatics in Europe is fragmented and slowly consolidates through acquisitions and mergers. Other life science sectors that rely on investments and partnerships with the bioinformatics market share are also anticipated to flourish.

Segmental Analysis

The global bioinformatics market is classified based on technology & service, application, sector, and region. 

On the Basis of Technology & Service

Based on technology & service, the fragments include knowledge management tools, bioinformatics platform, and bioinformatics services.

The bioinformatics services segment is projected to expand at a CAGR of 23.1% and hold the largest market share. Increases in data sequencing and analysis in the bioinformatics sector contribute to developing bioinformatics business services. The service industry is in its expansion phase and is anticipated to be profitable in the long run if it continues to receive excellent client feedback. Increased data extraction and consulting usage have resulted in a significant expansion of the service business. Outsourcing services like pharmaceutical and medical device industries use bioinformatics organizations to obtain research data quickly. Due to technological improvements, multiple sequence alignment and high throughput sequencing is the most profitable section of the sequencing market services market.

The knowledge management tools segment will hold the second-largest share. A knowledge management system (KMS) facilitates biological data collection, storage, and dissemination. Rapid changes in global competition, the expansion of information technology, and the development of low-cost storage technologies have permitted a paradigm shift in drug discovery. Almost all chemical and pharmaceutical firms rely heavily on knowledge management. They are creating new chemoinformatic units to support existing drug discovery projects. In addition, the growing demand for data integration, the increase in clinical trials, and the expansion of proteomic data all contribute to the development of the bioinformatics market. 

On the Basis of Application

Based on application, the fragments include Metabolomics, Molecular Phylogenetics, Transcriptomics, Proteomics, Chemoinformatic & Drug Design, Genomics, and Others.

The genomics segment is projected to expand at a CAGR of 11.3% and hold the largest market share. Genomics is the merging of genetics and bioinformatics that employs DNA and its sequencing techniques to assemble, analyze, and sequence the structure and function of genomes (DNA). Genomics applications include fine-scale genetic mapping and the sequencing of the whole DNA of living creatures. The expansion of the genomics sector is projected to be fueled by a rise in government spending and initiatives in genetic research. Due to its primary emphasis on drug discovery, the genomics market is anticipated to expand substantially within the personalized pharmaceuticals sector.

The chemoinformatic & drug design segment will hold the second-largest share. The definition of chemoinformatic is gathering resources to convert data into useful information and then to knowledge. And the drug development process involves the identification and optimization of potential leads. Lead identification facilitates activity in the low micromolar range, whereas lead optimization facilitates the transformation of leads into therapeutic candidates. There is a need for enhanced chemoinformatic systems due to the explosion of raw data from high throughput sequencing (HTS) and library creation. Incorporating drug discovery and chemical information is anticipated to aid in enhancing the drug discovery process, facilitating small-scale enterprises' participation in drug discovery research.

On the Basis of Sector

Based on sector, the fragments include Medical Bioinformatics, Animal Bioinformatics, Agriculture Bioinformatics, Academics, and Others.

The medical bioinformatics segment is projected to expand at a CAGR of 8.7% and hold the largest market share. Medical bioinformatics is a developing field that focuses on the study, development, and use of algorithms and frameworks to enhance the comprehension, communication, and management of medical data. In the bioinformatics industry, medication development is a critical application because it substantially lowers the cost and time related to drug research. Genomic solutions are utilized in numerous applications, including pharmaceutical innovation and production, solutions support and development, and other medical requirements. This is an excellent opportunity for the bioinformatics industry due to the rise of the genomics industry, which gives several options for the life science industry.

The other segment will hold the second-largest share. Others include microbial genome research, trash cleanup, climate change studies, and alternative energy sources. Microorganisms are prevalent, and it is simple to comprehend the base level of microbes by examining the genetic material of these organisms. In addition, the isolation of genes facilitates the comprehension of their uniqueness, which helps them to thrive in severe environments. Climate Change Studies, Evolutionary Studies, Bioweapon Creation, Waste Cleanup, Biotechnology, Antibiotic Resistance, Alternative Energy Sources, and Forensic Analysis of Microbes are various microbial genome applications.

Recent Developments

• In 2022, Agilent Technologies, Inc. announced to improve Alissa Reporter's processing rates for variant calling processes on the cloud-native platform of Agilent with the use of Amazon Elastic Compute Cloud G5g instances. 
• In 2022, Agilent Technologies, Inc. announced the launch of MassHunter BioConfirm 12.0 software that supports data produced by Agilent's high-resolution LC/MS for oligonucleotide purity analysis and sequence verification.